Health and Pharmaceuticals Social

There have been recognized specialists in the subject for some years now. Recently we have witnessed the rise of organized specialist research units linked to universities. Examples are the Research Centre for Economics and Health (CRES) at Pompeu Fabra University and the Health and Pharmaceuticals Social Studies Seminar at Carlos III University in Madrid. 

M. Cabanas Saenz Documentalist, Health and Pharmaceuticals Social Studies Seminar, Carlos III University, Madrid... 

BRS Online Products. This vendor comprises BRS Online Service, BRS/Colleague, BRS/After Dark, and BRS/Morning Search (35). The strength of BRS is in medical, physical, and social sciences as well as business and news databases of value to the health care and pharmaceutical industries... 

The three Health Ministers of the United Kingdom, in consultation with the medical and pharmaceutical professions and the ABPl, set up the Committee on Safety of Drugs (CSD) in June 1963. The three Health Ministers were the Secretary of State for Scotland, the Minister of Health and the Minister of Health and Social Services, Northern Ireland. 

In 1975, a paper was produced by the Professional Head of Medicines Division of the Department of Health and Social Security (DHSSKnow DoH) for consideration by the Medicines Commission. It was proposed that a new style BNF should be produced because the DHSS was concerned that doctors were being unduly influenced by promotional material produced by the pharmaceutical industry that was leading to an escalating medicines bill for the NHS. It was suggested that the New Style BNF should fulfill the following criteria ... 

Chemical products are of vital importance to the economic and social well being of our society in terms of trade and employment. Numerous chemical substances are used in a broad range of products and processes. They also help to improve the health and quality of life of the population through new developments such as in pharmaceuticals, food safety, pesticides and in many other products. During or after their use, these substances are released to the environment to a varying extent and may lead to pollution. This results in both ecological and - due to unnecessary losses - economic disadvantages. 

CRBPC s Rx D Code of Marketing Practice provides that member companies must not distribute service-oriented items or conduct "special promotions", which cannot be justified if subjected to scrutiny by members of the health professions and the public (CRBPC 2005). Acceptable service-oriented items are defined as items the primary goal of which is to enhance the healthcare practitioner s/patient s understanding of a condition or its treatment. When member companies provide hospitality, they must ensure that all hospitality is conducted within the limits of acceptable public and professional scrutiny, keeping in mind the need for an ethical relationship in any social interaction between healthcare professionals and pharmaceutical companies (CRBPC 2005). During such interactions, companies may provide participants with refreshments/meals that are modest in content and cost. In all instances, the provision of refreshments/meals must be clearly incidental. No other form of hospitality or entertainment is to be provided. 

The Transparency Commission is not only composed of mediccil-scientific groups but also of social groups and representatives from official pricing and reimbursement committees. Further, there cire university representatives (6), medical academies (2), general practitioners (2), insurance organisations (8), pharmacists (2), hospital pharmacists (1) and pharmaceutical industry (1). Delegates from the Ministry of Health, Ministry of Socicil Affairs and Ministry of Economic Affairs are also present. 

The first commission that formulates its advice is the Technical Council for Pharmaceutical Specialties. This council consists of pharmacists and physicians representing the Minister of Social Affairs, Public Health, universities, sickfunds, and the medical and pharmaceutical professions. This commission determines... 

The core administration, which consists of the Secretariat (including the Statistics and Information Department), and 11 bureaus, which are as follows Health Policy Bureau Health Service Bureau Social Welfare and War Victim s Relief Bureau Health and Welfare for Elderly Bureau Equal Employment, Children and Families Bureau Insurance Bureau Pension Bureau the Pharmaceutical and Food Safety Bureau (PFSB), which plays a major part in drug regulations and the Director-General for Policy Planning and Evaluation. Around 2000 officials work full-time in the central offices. 

The comprehensive care of hemophilia requires a multitude of health care professionals. The patient is best managed in specialized centers with trained personnel and appropriate laboratory, radiologic, and pharmaceutical services. The health care team includes hematologists, orthopedic surgeons, nurses, physical therapists, dentists, genetic counselors, psychologists, pharmacists, case managers, and social workers. 

Guidelines for the manufacture of sterile products, annex to the basic standards of good manufec-turing practice for pharmaceutical products (1973) Report PHI/73, EFTA Secretariat, Geneva Guide to good pharmaceutical manufecturing practice (1977) Department of Health and Social Security (HMSO), London... 

Good pharmaceutical manufacturing practice applied to the hospital preparation of radiopharmaceuticals (1977) Dept, of Health and Social Security, notes for guidance issued by the Medicines Inspectorate, London... 

Good Pharmaceutical Manufacturing Practices in Korea (KGMP) Ministry of Health and Social Affairs (MOSHA)... 

Pharmaceuticals and medical preparations manufacturing premises should maintain records of complaints on product quality and adverse reactions and investigate the reasons of complaints. Ministry of Health and Social Assistance should immediately be informed on any incident that may be hazardous to health. 

Department of Health, Easter Access to Modern Treatment How NICE appraisal wiU work. Puh. DoH, London, 1999. EU, L.S.E. Panos Kanavos, Health and social care Overview of pharmaceutical pricing and reimhursement regulation in Europe, http //dg3.eudra.org/E3/G10/docs, accessed February 19, 2002. 

---